Forget This Biotech Stock’s Rally Signals Fresh Jump
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Understand factors that indicate long-term growth potential in crypto coins and how to select those with staying power.
27,742 articlesNovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Antalpha's bold bet on tokenized gold XAUt has yielded more than $100 million in unrealized gains, with a recent tran...
Playnance has kicked off GCOIN trading on MEXC, signaling a key expansion of its Web3 entertainment network. Early me...
A major European energy firm plans to halt offshore wind projects off the U.S. East Coast and redirect about $1B into...
Investors are recalibrating after airports report faster screening and shorter lines, sparking a mixed revaluation of...
Sui Group's Q1 2026 results shed light on the company’s momentum and future path. This analysis breaks down the numbe...
Great Elm's Q3 2026 earnings shed light on growth, margins, and capital allocation. This article breaks down the numb...
Cisco posts record quarterly revenue as AI infrastructure orders rise, fueling renewed bets on CSCO. The article exam...
Institutional funds continue to flow into XRP as Citadel joins Ripple’s latest funding round, sparking expectations t...
Elon Musk’s clash with OpenAI doubles as a bid to launch xAI, with Tesla financing and strategic partnerships setting...
Onity wins approval revised terms for a major reverse mortgage MSR sale to FOA, narrowing the portfolio and shifting ...
A former Republican congressman receives a presidential pardon from Trump, erasing insider-trading gains tied to a ma...